Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Is CNinsure Inc. (ADR) (CISG) Going to Burn These Hedge Funds?

Page 1 of 2

Is CNinsure Inc. (ADR) (NASDAQ:CISG) an exceptional investment today? The best stock pickers are in a bearish mood. The number of long hedge fund positions stayed the same which is a slightly negative development in our experience

In the financial world, there are plenty of methods investors can use to analyze the equity markets. A pair of the best are hedge fund and insider trading activity. At Insider Monkey, our research analyses have shown that, historically, those who follow the top picks of the elite fund managers can outclass the S&P 500 by a solid margin (see just how much).

David Shaw

Just as key, bullish insider trading sentiment is a second way to parse down the marketplace. Obviously, there are a number of stimuli for a bullish insider to downsize shares of his or her company, but just one, very clear reason why they would buy. Several empirical studies have demonstrated the impressive potential of this tactic if “monkeys” understand what to do (learn more here).

With these “truths” under our belt, it’s important to take a peek at the key action encompassing CNinsure Inc. (ADR) (NASDAQ:CISG).

How have hedgies been trading CNinsure Inc. (ADR) (NASDAQ:CISG)?

At year’s end, a total of 5 of the hedge funds we track held long positions in this stock, a change of 0% from one quarter earlier. With hedgies’ positions undergoing their usual ebb and flow, there exists a select group of noteworthy hedge fund managers who were boosting their stakes significantly.

Of the funds we track, Jim Simons’s Renaissance Technologies had the largest position in CNinsure Inc. (ADR) (NASDAQ:CISG), worth close to $2.8 million, accounting for less than 0.1%% of its total 13F portfolio. The second largest stake is held by D. E. Shaw of D E Shaw, with a $1.3 million position; the fund has less than 0.1%% of its 13F portfolio invested in the stock. Remaining hedge funds that hold long positions include Israel Englander’s Millennium Management, Prem Watsa’s Fairfax Financial Holdings and John Overdeck and David Siegel’s Two Sigma Advisors.

Because CNinsure Inc. (ADR) (NASDAQ:CISG) has witnessed a declination in interest from the aggregate hedge fund industry, we can see that there is a sect of fund managers that slashed their positions entirely heading into 2013. At the top of the heap, Ken Griffin’s Citadel Investment Group sold off the biggest position of all the hedgies we key on, valued at about $0.1 million in stock. These transactions are intriguing to say the least, as aggregate hedge fund interest stayed the same (this is a bearish signal in our experience).

What do corporate executives and insiders think about CNinsure Inc. (ADR) (NASDAQ:CISG)?

Insider purchases made by high-level executives is most useful when the company in question has seen transactions within the past half-year. Over the last 180-day time period, CNinsure Inc. (ADR) (NASDAQ:CISG) has seen zero unique insiders buying, and zero insider sales (see the details of insider trades here).

Let’s also review hedge fund and insider activity in other stocks similar to CNinsure Inc. (ADR) (NASDAQ:CISG). These stocks are Erie Indemnity Company (NASDAQ:ERIE), National Financial Partners Corp. (NYSE:NFP), CorVel Corporation (NASDAQ:CRVL), Crawford & Company (NYSE:CRD-B), and eHealth, Inc. (NASDAQ:EHTH). All of these stocks are in the insurance brokers industry and their market caps match CISG’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!